Показано 0 из 0
Дата |
---|
07.05.2024 |
06.05.2024 |
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
3.256
|
3.502
|
3.466
|
3.36
|
3.474
|
3.36
|
|
|
|
|
3.326
|
3.576
|
3.412
|
3.41
|
3.434
|
3.434
|
|
|
|
|
3.316
|
3.566
|
3.316
|
3.316
|
3.47
|
3.45
|
|
|
|
|
3.176
|
3.416
|
3.374
|
3.25
|
3.47
|
3.298
|
|
|
|
|
3.11
|
3.344
|
3.208
|
3.202
|
3.254
|
3.254
|
|
|
|
|
3.114
|
3.35
|
3.31
|
3.266
|
3.386
|
3.344
|
|
|
|
|
3.202
|
3.444
|
3.248
|
3.212
|
3.286
|
3.25
|
|
|
|
|
3.112
|
3.358
|
3.204
|
3.108
|
3.204
|
3.202
|
|
|
|
|
3.076
|
3.308
|
3.198
|
3.194
|
3.276
|
3.258
|
|
|
|
|
3.056
|
3.288
|
3.038
|
2.974
|
3.20
|
3.19
|
|
|
|
|
Tempest Therapeutics Inc. operates as a development-stage biotechnology company. The Company focuses on targeted and immune-eediated cancer therapies that modulate anti-tumor immunity pathways. Tempest Therapeutics serves customers worldwide.